Exact Mass: 428.2073
Exact Mass Matches: 428.2073
Found 500 metabolites which its exact mass value is equals to given mass value 428.2073
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Austalide L
Austalide L is a mycotoxin produced by Aspergillus ustu
Taraxacolide 1-O-b-D-glucopyranoside
*Constituent of Taraxacum officinale (dandelion). Taraxacolide 1-O-b-D-glucopyranoside is found in many foods, some of which are coffee and coffee products, beverages, alcoholic beverages, and tea. Taraxacolide 1-O-b-D-glucopyranoside is found in alcoholic beverages. *Taraxacolide 1-O-b-D-glucopyranoside is a constituent of Taraxacum officinale (dandelion
Pyridinoline
Derived from collagen cross-links formed between adjacent hydroxylysine residues in type I and type II collagen of bone and cartilage respectively. Released into serum during bone resorption Pyridinoline is a breakdown product of bone collagen. It can be used as a bone marker to measure osteoclastic activity.
1-(3-(4-Phenylbenzyl)-4-hydroxychroman-7-yl)cyclopentane-1-carboxylic acid
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D020024 - Leukotriene Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists
Xanthine amine congener
Zaldaride
C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals
Hypochoeroside A
Hypochoeroside a belongs to germacranolides and derivatives class of compounds. Those are sesquiterpene lactones with a structure based on the germacranolide skeleton, characterized by a gamma lactone fused to a 1,7-dimethylcyclodec-1-ene moiety. Hypochoeroside a is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Hypochoeroside a can be found in endive, which makes hypochoeroside a a potential biomarker for the consumption of this food product.
Isomajdine
D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids Annotation level-1
Sphaeranthanolide
Sonchuside F
Sonchuside G
11beta,13-dihydroparthenolide-14-O-beta-D-glucopyranoside
(E,E)-3beta-O-beta-D-glucopyranosyl-9beta-hydroxy-6beta,7alpha,11betaH-germacra-1(10),4-dien-12,6-olide|scorzoaustriacoside
4alpha,5alpha-epoxy-10alpha,11beta,13H,14H-1-epi-inuviscolide 3-beta-D-glucoside
(5-angeloyloxytiglinoyloxy)-costunolide|<5-angeloyloxytiglinoyloxy>-costunolide
(2R,4S)-2-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-2,4-pentanediol
(1R,2S,4S,5R,6R,9S)-2-hydroxy-11-oxoallocedra-13-oic acid 13-O-beta-D-glucopyranosyl ester
14-O-beta-D-glucopyranosyl-6-deoxy-3,4-dehydrofloridanolide|dunnianolide A
1-(2-Amino-1-oxopropyl)-2,3,3alpha, 13alpha, 14,15,16,18alpha-octahydro-8-methoxy-5,9-metheno-9H-dipyrrolo[3,2-b:1,2-e][1,5,8]oxadiazacyclopentadecine-13,18-(1H,12H)-dione
(19S)-17,19-epoxy-10,11-dimethoxy-7-oxo-1,7-dihydro-(20alphaH)-2xi,6-cyclo-6,7-seco-coryn-16-ene-16-carboxylic acid methyl ester|(2S,3S,15S,19S,20S)-isoreserpiline pseudoindoxyl|10,11-dimethoxy-19alpha-methyl-7-oxo-1,7-dihydro-(20alpha)-18-oxa-2xi,6-cyclo-6,7-seco-yohimb-16-ene-16-carboxylic acid methyl ester|Isoreserpilin-pseudoindoxyl|Isoreserpilin-Psi-indoxyl|isoreserpiline pseudoindoxyl
1beta-[(E-p-methoxycinnamoyl)oxy]-6alpha-hydroxyisodrimeninol
4alpha-hydroxy-5alpha,8betaH-eudesman-7(11)-en-8alpha,12-olide-15-O-beta-D-glucopyranoside|sarcaglaboside H
3beta-hydroxy-4aH-3-dihydrosantamarine-1beta-D-glucopyranoside
CAY10594
CAY10594 is a potent phospholipase D2 (PLD2) inhibitor both in vitro (IC50=140 nM) and in cells (IC50=110 nM)[1]. CAY10594 strongly inhibits the invasive migration of breast cancer cells in vitro and ameliorates acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis[2].
Isocarapanaubine
(2R,2R,4aS,6R,8aS)-6,7-diformyl-4-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydro-2H,3H-spiro[benzofuran-2,1-naphthalen]-6-yl acetate
((S)-2-((E)-6-((R)-3,3-dimethyloxiran-2-yl)-4-methylhex-3-en-1-yl)-8-formyl-5-hydroxy-2-methyl-2H-chromen-7-yl)methyl acetate
Majdine
D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids Origin: Plant; SubCategory_DNP: Alkaloids derived from tryptophan, Secologanin typtamine alkaloids, Indole alkaloids
Elegantine
Origin: Plant; Formula(Parent): C23H28N2O6; Bottle Name:Isomajdine; PRIME Parent Name:Isomajdine; PRIME in-house No.:V0302; SubCategory_DNP: Alkaloids derived from tryptophan, Secologanin typtamine alkaloids, Indole alkaloids PRIME Parent Name:Isomajdine; Origin: Plant; Formula(Parent): C23H28N2O6; Bottle Name:Isomajdine; PRIME in-house No.:V0302; SubCategory_DNP: Alkaloids derived from tryptophan, Secologanin typtamine alkaloids, Indole alkaloids
Ala Glu Ile Pro
Ala Glu Leu Pro
Ala Glu Pro Ile
Ala Glu Pro Leu
Ala His Thr Thr
Ala Ile Glu Pro
Ala Ile Pro Glu
Ala Leu Glu Pro
Ala Leu Pro Glu
Ala Asn Pro Gln
Ala Asn Gln Pro
Ala Pro Glu Ile
Ala Pro Glu Leu
Ala Pro Ile Glu
Ala Pro Leu Glu
Ala Pro Asn Gln
Ala Pro Gln Asn
Ala Gln Asn Pro
Ala Gln Pro Asn
Ala Thr His Thr
Ala Thr Thr His
Cys Ile Pro Pro
Cys Leu Pro Pro
Cys Pro Ile Pro
Cys Pro Leu Pro
Cys Pro Pro Ile
Cys Pro Pro Leu
Asp Pro Pro Thr
Asp Pro Thr Pro
Asp Pro Val Val
Asp Thr Pro Pro
Asp Val Pro Val
Asp Val Val Pro
Glu Ala Ile Pro
Glu Ala Leu Pro
Glu Ala Pro Ile
Glu Ala Pro Leu
Glu Ile Ala Pro
Glu Ile Pro Ala
Glu Leu Ala Pro
Glu Leu Pro Ala
Glu Pro Ala Ile
Glu Pro Ala Leu
Glu Pro Ile Ala
Glu Pro Leu Ala
Glu Pro Pro Ser
Glu Pro Ser Pro
Glu Ser Pro Pro
Gly Pro Gln Gln
Gly Gln Pro Gln
Gly Gln Gln Pro
His Ala Thr Thr
His Cys Ala Val
His Ile Cys Gly
His Ile Gly Cys
His Leu Cys Gly
His Leu Gly Cys
His Met Ala Ala
His Ser Ser Val
His Ser Val Ser
His Thr Ala Thr
His Thr Thr Ala
His Val Ala Cys
His Val Cys Ala
His Val Ser Ser
Ile Ala Glu Pro
Ile Ala Pro Glu
Ile Cys Gly His
Ile Cys His Gly
Ile Cys Pro Pro
Ile Glu Ala Pro
Ile Glu Pro Ala
Ile Gly Cys His
Ile Gly His Cys
Ile His Cys Gly
Ile Pro Ala Glu
Ile Pro Cys Pro
Ile Pro Glu Ala
Ile Pro Pro Cys
Leu Ala Glu Pro
Leu Ala Pro Glu
Leu Cys Pro Pro
Leu Glu Ala Pro
Leu Glu Pro Ala
Leu Pro Ala Glu
Leu Pro Cys Pro
Leu Pro Glu Ala
Leu Pro Pro Cys
Asn Ala Pro Gln
Asn Ala Gln Pro
Asn Pro Ala Gln
Asn Pro Gln Ala
Asn Gln Ala Pro
Asn Gln Pro Ala
Pro Ala Glu Ile
Pro Ala Glu Leu
Pro Ala Ile Glu
Pro Ala Leu Glu
Pro Ala Asn Gln
Pro Ala Gln Asn
Pro Cys Ile Pro
Pro Cys Leu Pro
Pro Cys Pro Ile
Pro Cys Pro Leu
Pro Asp Pro Thr
Pro Asp Thr Pro
Pro Asp Val Val
Pro Glu Ala Ile
Pro Glu Ala Leu
Pro Glu Ile Ala
Pro Glu Leu Ala
Pro Glu Pro Ser
Pro Glu Ser Pro
Pro Gly Gln Gln
Pro Ile Ala Glu
Pro Ile Cys Pro
Pro Ile Glu Ala
Pro Ile Pro Cys
Pro Leu Ala Glu
Pro Leu Cys Pro
Pro Leu Glu Ala
Pro Leu Pro Cys
Pro Asn Ala Gln
Pro Asn Gln Ala
Pro Pro Cys Ile
Pro Pro Cys Leu
Pro Pro Asp Thr
Pro Pro Glu Ser
Pro Pro Ile Cys
Pro Pro Leu Cys
Pro Pro Ser Glu
Pro Pro Thr Asp
Pro Gln Ala Asn
Pro Gln Gly Gln
Pro Gln Asn Ala
Pro Gln Gln Gly
Pro Ser Glu Pro
Pro Ser Pro Glu
Pro Thr Asp Pro
Pro Thr Pro Asp
Pro Val Asp Val
Pro Val Val Asp
Gln Ala Asn Pro
Gln Ala Pro Asn
Gln Gly Pro Gln
Gln Gly Gln Pro
Gln Asn Ala Pro
Gln Asn Pro Ala
Gln Pro Ala Asn
Gln Pro Gly Gln
Gln Pro Asn Ala
Gln Pro Gln Gly
Gln Gln Gly Pro
Gln Gln Pro Gly
Ser Glu Pro Pro
Ser His Ser Val
Ser His Val Ser
Ser Pro Glu Pro
Ser Pro Pro Glu
Ser Ser His Val
Ser Ser Val His
Ser Val His Ser
Ser Val Ser His
Thr Ala His Thr
Thr Ala Thr His
Thr Asp Pro Pro
Thr His Ala Thr
Thr His Thr Ala
Thr Pro Asp Pro
Thr Pro Pro Asp
Thr Thr Ala His
Thr Thr His Ala
Val Asp Pro Val
Val Asp Val Pro
Val His Ser Ser
Val Pro Asp Val
Val Pro Val Asp
Val Ser His Ser
Val Ser Ser His
Val Val Asp Pro
Val Val Pro Asp
Austalide L
Taraxacolide 1-O-b-D-glucopyranoside
9beta-hydroxy-11beta,13-dihydro-parthenolide-9-O-beta-D-glucopyranoside
9alpha-hydroxy-11beta,13-dihydro-parthenolide-9-O-beta-D-glucopyranoside
(S)-N-(2-HYDROXY-2-METHYL-1-PHENYL-PROPYL)-4-METHYL-BENZENESULFONAMIDE
1H-Azepine,hexahydro-1-[[[1-[2-(4-methyl-1-piperidinyl)-2-oxoethyl]-1H-benzimidazol-2-yl]thio]acetyl]-(9CI)
Pregna-1,4-dien-21-al, 16,17-[butylidenebis(oxy)]-11-hydroxy-3,20-dioxo-, (11β,16α)
L-Tyrosine,N-[(phenylmethoxy)carbonyl]-L-valyl-, methyl ester
5-O-tert-Butyldiphenylsilyl-2,3-O-isopropylidene-D-ribofuranose
2,2-azobis[2-[1-(2-hydroxyethyl)-2-imidazolin-2-yl]propane] dihydrochloride monohydrate
8-(4-([1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YL)-3-(6-METHYLPYRIDIN-2-YL)-1H-PYRAZOL-1-YL)-2-OXASPIRO[4.5]DECAN-1-ONE
1H-Benzimidazole-1-acetamide,N-cyclopentyl-2-[[2-(2,6-dimethyl-1-piperidinyl)-2-oxoethyl]thio]-(9CI)
Olmesartan lactone impurity
Olmesartan lactone impurity is a cyclic ester impurity of Olmesartan. Olmesartan is an angiotensin II receptor (AT1R) antagonist and has the potential for high blood pressure study[1][2].
ADL5859 HCl
ADL-5859 hydrochloride (compound 20) is a selective and orally active δ opioid receptor (DOR) agonist with an Ki and an EC50 value of 0.84 and 20 nM, respectively. ADL-5859 hydrochloride also shows inhibitory activity to hERG channel with an IC50 value of 78 μM. ADL-5859 hydrochloride can be used for the research of pain[1][2].
butanedioic acid,sulfo-,4-dodecyl 1-(2-propenyl)ester,sodium salt
Dopexamine hydrochloride
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Dopexamine hydrochloride is a β2 adrenergic receptor agonist.
pseudoephedrine sulfate
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
Ephedrine sulfate
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
N-[2-(2,4-Diaminopyrido[2,3-D]pyrimidin-7-Yl)-2-Methylpropyl]-4-Phenoxybenzamide
9-Cyclopentyl-6-[2-(3-imidazol-1-YL-propoxy)-phenylamino]-9H-purine-2-carbonitrile
N-[2-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl]naphthalene-2-carboxamide
CAY10594 is a potent phospholipase D2 (PLD2) inhibitor both in vitro (IC50=140 nM) and in cells (IC50=110 nM)[1]. CAY10594 strongly inhibits the invasive migration of breast cancer cells in vitro and ameliorates acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis[2].
[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] dodecanoate
N(2)-[3-methoxy-4-(morpholin-4-yl)phenyl]-N(4)-(quinolin-3-yl)pyrimidine-2,4-diamine
Methyl (1S,4aS,5aR,6R,10aS)-6,7-dimethoxy-1-methyl-2-oxospiro[1,4a,5,5a,7,8,10,10a-octahydropyrano[3,4-f]indolizine-6,3-1H-indole]-4-carboxylate
2-[[4-(2,3-Dimethylphenyl)-1-piperazinyl]-oxomethyl]-1,5-dimethyl-4-pyrrolo[3,2-c]quinolinone
[4-[2-(4-Methoxyphenyl)-5-methyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]-(3-pyridinyl)methanone
N-[2-(2-benzamidoethyl)-1-methyl-5-benzimidazolyl]-2-methoxybenzamide
2-(4-methyl-N-(4-methylphenyl)sulfonylanilino)-N-[(1-methyl-4-piperidinylidene)amino]acetamide
N-(3-fluoro-4-methylphenyl)-4-[3-(4-methyl-1-piperidinyl)propylamino]-3-nitrobenzamide
11-{[(E)-furan-2-ylmethylidene]amino}-3-hexyl-2-methyl-3,11-dihydro-4H-pyrimido[5,4:4,5]pyrrolo[2,3-b]quinoxalin-4-one
[(2S,3R)-6-(1,3-benzodioxol-5-ylmethyl)-3-phenyl-1-(phenylmethyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol
N-(cyclohexylmethyl)-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
1-[(3aS,4R,9bS)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
1-[(2S,3R)-2-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-2-(2-pyridinyl)ethanone
(6S,7S,8S)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
N-(cyclohexylmethyl)-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
[(3aR,4R,9bR)-8-(1-cyclohexenyl)-1-[(1-methyl-4-imidazolyl)sulfonyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
1-[(3aR,4S,9bR)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
1-[(3aR,4R,9bR)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
1-[(3aS,4S,9bS)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
1-[(2S,3S)-2-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-2-(2-pyridinyl)ethanone
(6S,7R,8R)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8S)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8S)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
2-[[(2R)-2-(8-carboxyoctanoyloxy)-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-(8-carboxyoctanoyloxy)-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
methyl (1S,6R)-6,7-dimethoxy-1-methyl-2-oxospiro[1,4a,5,5a,7,8,10,10a-octahydropyrano[3,4-f]indolizine-6,3-1H-indole]-4-carboxylate
[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] dodecanoate
(2-hydroxy-3-phosphonooxypropyl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
Zaldaride
C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals
GSK2194069
GSK2194069 is a potent inhibitor of β-ketoyl reductase (KR) of fatty acid synthase (FASN), with an IC50 value of 7.7 nM. GSK2194069 shows specifically inhibitory effect on FAS expressing cancer cells, by acting potent efficacy on acetoacetyl-CoA, NADPH with IC50 or Ki values of 4.8 nM and 5.6 nM, respectively[1][2][3].
3,4a,5-trimethyl-6-[(2-methylbut-2-enoyl)oxy]-9-oxo-4h,5h,6h,7h,8h,8ah-naphtho[2,3-b]furan-4-yl 3-methylbut-2-enoate
(4ar,5r,8ar,9as)-5-hydroxy-3,8a-dimethyl-5-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-4h,4ah,6h,7h,8h,9h,9ah-naphtho[2,3-b]furan-2-one
(1s,2r,4r,7z,11s,12s)-4,12-dimethyl-8-({[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-7-en-13-one
(3s,3as,9r,11as)-6-(hydroxymethyl)-3,10-dimethyl-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
(3s,3ar,4ar,5s,6r,7ar,9ar)-5-hydroxy-3,5,8-trimethyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,4ah,6h,7h,7ah,9ah-azuleno[6,5-b]furan-2-one
(3s,3as,5ar,6r,9s,9as,9bs)-3,5a,9-trimethyl-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3h-naphtho[1,2-b]furan-2,8-dione
(3s,3as,9s,11ar)-6-(hydroxymethyl)-3,10-dimethyl-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
19-hydroxy-10-methoxy-1,4,14,18,18-pentamethyl-2,7-dioxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-3,5(9),10-triene-8,17-dione
(3s,3ar,4s,6s,7r,7as)-6-ethenyl-4-hydroxy-3,6-dimethyl-7-[(1e)-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}prop-1-en-2-yl]-hexahydro-1-benzofuran-2-one
3,4a,5-trimethyl-6-[(3-methylbut-2-enoyl)oxy]-9-oxo-4h,5h,6h,7h,8h,8ah-naphtho[2,3-b]furan-4-yl 3-methylbut-2-enoate
3,5a-dimethyl-2-oxo-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydronaphtho[1,2-b]furan-9-carbaldehyde
9-(hydroxymethyl)-5a-methyl-3-methylidene-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3ah-naphtho[1,2-b]furan-2-one
20-hydroxy-10-methoxy-1,4,14,18,18-pentamethyl-2,7-dioxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-3,5(9),10-triene-8,17-dione
5,9a-dihydroxy-5b,9,9,11a-tetramethyl-2-(penta-1,3-dien-1-yl)-5,5a,6,7,10,11-hexahydro-1,12-dioxatetraphene-4,8-dione
(3s,3as,9s,11as)-6-(hydroxymethyl)-3,10-dimethyl-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
6-ethenyl-4-hydroxy-3,6-dimethyl-7-(1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}prop-1-en-2-yl)-hexahydro-1-benzofuran-2-one
methyl (1's,3r,4'as,5'as,10'as)-2-hydroxy-6,7-dimethoxy-1'-methyl-1',4'a,5',5'a,7',8',10',10'a-octahydrospiro[indole-3,6'-pyrano[3,4-f]indolizine]-4'-carboxylate
(4s,4ar,5r,6s,8as)-3,4a,5-trimethyl-6-[(3-methylbut-2-enoyl)oxy]-9-oxo-4h,5h,6h,7h,8h,8ah-naphtho[2,3-b]furan-4-yl (2z)-2-methylbut-2-enoate
2-{3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-1h,2h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}propanoic acid
10-({4-[2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl}oxy)-10-oxodeca-2,4,6,8-tetraenoic acid
(3s,3ar,4s,6ar,8s,9s,9ar,9br)-4-hydroxy-3,9-dimethyl-6-methylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydroazuleno[4,5-b]furan-2-one
20r,21-epoxyresibufogenin 3-formate
{"Ingredient_id": "HBIN003438","Ingredient_name": "20r,21-epoxyresibufogenin 3-formate","Alias": "NA","Ingredient_formula": "C25H32O6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7189","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
20s,21-epoxyresibufogenin 3-formate
{"Ingredient_id": "HBIN003472","Ingredient_name": "20s,21-epoxyresibufogenin 3-formate","Alias": "NA","Ingredient_formula": "C25H32O6","Ingredient_Smile": "CC12CCC(CC1CCC3C2CCC4(C35C(O5)CC4C67C=CC(=O)OC6O7)C)OC=O","Ingredient_weight": "428.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7190","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101244896","DrugBank_id": "NA"}